GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE Healthcare Technologies Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
GE Healthcare Technologies Inc 주요 수익원은 Product이며, 최신 수익 발표에서 수익은 13,661,000,000입니다. 지역별로는 USCAN이 GE Healthcare Technologies Inc의 주요 시장이며, 수익은 9,531,000,000입니다.
GE Healthcare Technologies Inc은 수익성이 있나요?
예, 최신 재무제표에 따르면 GE Healthcare Technologies Inc의 순이익은 $2,084입니다.
GE Healthcare Technologies Inc에 부채가 있나요?
예, GE Healthcare Technologies Inc의 부채는 26,527입니다.
GE Healthcare Technologies Inc의 발행 주식은 몇 주인가요?
GE Healthcare Technologies Inc의 총 발행 주식은 455.73주입니다.